News

WASHINGTON, Dec 4, 00 (LSN.ca) – The American Medical Association (AMA) and The American College of Obstetricians and Gynecologists (ACOG) have once again gone far beyond the call of duty in promoting abortion. Last week ACOG put out a news release promoting the use of Misoprostol in conjunction with Mifepristone (RU-486) in order to counter the drug manufacturers warning against such use of its product. Meanwhile the AMA is set to encourage the over-the-counter distribution of the abortifacient morning-after-pill.

See the press release by ACOG https://www.acog.org/from_home/publications/press_releases/nr11-30-00-3.htm

See the AMA info on MAP https://www.boston.com/dailyglobe2/337/nation/AMA_backs_access_to_morning_after_pill+.shtml

See related LifeSite on Searle and an MAP resource:  https://www.lifesitenews.com/ldn/2000/oct/001013.html#3 https://www.morningafterpill.org/

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.